Análise do Câncer de Glândula Salivar antes e durante a Pandemia de Covid-19 no Brasil
DOI:
https://doi.org/10.32635/2176-9745.RBC.2025v71n2.4800Palavras-chave:
Neoplasias Bucais, Neoplasias de Glândulas Salivares, Tempo para o Tratamento, COVID-19Resumo
Introdução: A pandemia de covid-19 gerou impacto negativo na prestação de serviços de saúde, incluindo atrasos no diagnóstico e no início do tratamento do câncer. Objetivo: Analisar e comparar o número de registros de casos de câncer de glândulas salivares (CGS), estadiamentos e tempo para o início de tratamento (TT) de 2019 a 2022 no Brasil. Método: Os dados sobre o registro de CGS, sexo, faixa etária, tipo de tratamento, estadiamento e TT foram coletados do Painel-Oncologia. Foi realizada análise descritiva das variáveis e o teste de Friedman foi utilizado para comparar o número de registros de CGS, estadiamento e TT entre os anos analisados (p<0,05), utilizando SPSS v.22.0. Resultados: Para todos os anos analisados, os registros de CGS foram mais prevalentes no sexo masculino a partir da quinta década de vida; cirurgia e radioterapia foram as modalidades terapêuticas mais utilizadas; e os estágios IV e III foram os mais prevalentes sempre que o estadiamento foi registrado. O TT <30 dias foi predominante em todos os períodos, seguido do TT >60 dias. Os registros de CGS, estadiamento e TT apresentaram variações medianas entre os períodos pré e transpandêmico, mas sem diferenças estatisticamente significativas (p>0,05). Conclusão: Não foram identificadas diferenças significativas nos registros de CGS, estadiamento e TT nos Estados brasileiros, antes e durante a pandemia de covid-19. Esses resultados sugerem que o sistema público de saúde brasileiro conseguiu manter a consistência da assistência oncológica, mesmo durante a pandemia de covid-19.
Downloads
Referências
Speight PM, Barrett AW. Salivary gland tumours. Oral Dis. 2002;8(5):229-40. doi: https://www.doi.org/10.1034/j.1601-0825.2002.02870.x DOI: https://doi.org/10.1034/j.1601-0825.2002.02870.x
Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: cancer today [Internet]. Lyon: International Agency for Research on Cancer; 2020. [acesso 2023 dec 12]. Disponível em: https://gco.iarc.fr/today
Hacioglu MB, Erdogan B, Bardakcı M, et al. Major and minor salivary gland cancers: a multicenter retrospective study. Head Neck. 2023;45(7):1643-53. doi: https://www.doi.org/10.1002/hed.27376. DOI: https://doi.org/10.1002/hed.27376
Nachtsheim L, Mayer M, Meyer MF, et al. Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany. J Cancer Res Clin Oncol. 2023;149(7):3811-21. doi: https://www.doi.org/10.1007/s00432-022-04278-6 DOI: https://doi.org/10.1007/s00432-022-04278-6
Leopard D, El-Hitti E, Puttasiddaiah P, et al. Twenty-seven years of primary salivary gland carcinoma in Wales: an analysis of histological subtype and associated risk factors. J Laryngol Otol. 2022;136(2):167-72. doi: https://www.doi.org/10.1017/S002221512200007X DOI: https://doi.org/10.1017/S002221512200007X
Pan SY, Groh M, Morrison H. A case-control study of risk factors for salivary gland cancer in Canada. J Cancer Epidemiol. 2017;2017:4909214. doi: https://www.doi.org/10.1155/2017/4909214 DOI: https://doi.org/10.1155/2017/4909214
Xu W, Wang Y, Qi X, et al. Prognostic factors of palatal mucoepidermoid carcinoma: a retrospective analysis based on a double-center study. Sci Rep. 2017;7:43907. doi: https://www.doi.org/10.1038/srep43907 DOI: https://doi.org/10.1038/srep43907
Cantù G. Adenoid cystic carcinoma. An indolent but aggressive tumour. Part A: from aetiopathogenesis to diagnosis. Acta Otorhinolaryngol Ital. 2021;41(3):206-14. doi: https://www.doi.org/10.14639/0392-100X-N1379 DOI: https://doi.org/10.14639/0392-100X-N1379
Santos TS, Melo DG, Andrade ESS, et al. Carcinoma mucoepidermóide no palato: relato de caso. Rev Port Estomatol Med Dent Cir Maxilofac. 2012;53(1):29-33. doi: https://www.doi.org/10.1016/j.rpemd.2011.11.002 DOI: https://doi.org/10.1016/j.rpemd.2011.11.002
Nakaguro M, Tada Y, Faquin WC, et al. Salivary duct carcinoma: updates in histology, cytology, molecular biology, and treatment. Cancer Cytopathol. 2020;128(10):693-703. doi: https://www.doi.org/10.1002/cncy.22288 DOI: https://doi.org/10.1002/cncy.22288
Lucena MEA, Almeida HCR, Silva LP, et al. Local recurrences of salivary gland tumors in a Brazilian population. Clin Lab Res Den. 2022:1-11. doi: https://www.doi.org/10.11606/issn.2357-8041.clrd.2022.194477
Dhanuthai K, Rojanawatsirivej S, Thosaporn W, et al. Oral cancer: a multicenter study. Med Oral Patol Oral Cir Bucal. 2018;23(1):e23-9. doi: https://www.doi.org/10.4317/medoral.21999
Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21(8):1023-34. doi: https://www.doi.org/10.1016/S1470-2045(20)30388-0 DOI: https://doi.org/10.1016/S1470-2045(20)30388-0
Sud A, Torr B, Jones ME, et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020;21(8):1035-44. doi: https://www.doi.org/10.1016/S1470-2045(20)30392-2 DOI: https://doi.org/10.1016/S1470-2045(20)30392-2
Patt D, Gordan L, Diaz M, et al. Impact of COVID-19 on cancer care: how the pandemic is delaying cancer diagnosis and treatment for American seniors. JCO Clin Cancer Inform. 2020;4:1059-71. doi: https://www.doi.org/10.1200/CCI.20.00134 DOI: https://doi.org/10.1200/CCI.20.00134
Gršić K, Blivajs I, Pastorčić Grgić M, et al. The impact of covid-19 on head and neck cancer treatment delay. Acta Clin Croat. 2022;61(Supl 4):19-25. doi: https://www.doi.org/10.20471/acc.2022.61.s4.2 DOI: https://doi.org/10.20471/acc.2022.61.s4.2
Ministério da Saúde (BR). Portaria Nº 913, de 22 de abril de 2022. Declara o encerramento da Emergência em Saúde Pública de Importância Nacional (ESPIN) em decorrência da infecção humana pelo novo coronavírus (2019-nCoV) e revoga a Portaria GM/MS nº 188, de 3 de fevereiro de 2020 [Internet]. Diário Oficial da União, DF. 2022 abr 22 [access 2024 feb 20]; Edição Extra 1; Seção 1:1. Available from: https://www.planalto.gov.br/ccivil_03/Portaria/PRT/Portaria-913-22-MS.htm
Moura EC, Cortez-Escalante J, Cavalcante FV, et al. Covid-19: temporal evolution and immunization in the three epidemiological waves, Brazil, 2020-2022. Rev Saude Publica. 2022;56:105. doi: https://www.doi.org/10.11606/s1518-8787.2022056004907 DOI: https://doi.org/10.11606/s1518-8787.2022056004907
TABNET [Internet]. Brasília (DF): DATASUS. c2008 – [acesso 2023 Dec 15]. Disponível em:http://tabnet.datasus.gov.br/cgi/dhdat.exe?PAINEL_ONCO/PAINEL_ONCOLOGIABR.def
Ministério da Saúde (BR). Lei nº 12.732, de 22 de novembro de 2012. Dispõe sobre o primeiro tratamento de paciente com neoplasia maligna comprovada e estabelece prazo para seu início [Internet]. Diário Oficial da União, Brasília, DF. 2012 out 23 [acess 2023 nov 16]; Edição 226; Seção 1:1. Available from: http://www.planalto.gov.br/ccivil_03/_ato2011-2014/2012/lei/l12732.htm
SPSS®: Statistical Package for Social Science (SPSS)[Internet]. Versão 22.0. [Nova York]. International Business Machines Corporation. [acesso 2024 mar 9]. Disponível em: https://www.ibm.com/br-pt/spss?utm_content=SRCWW&p1=Search&p4=43700077515785492&p5=p&gclid=CjwKCAjwgZCoBhBnEiwAz35Rwiltb7s14pOSLocnooMOQh9qAL59IHVc9WP4ixhNTVMjenRp3-aEgxoCubsQAvD_BwE&gclsrc=aw.ds
Conselho Nacional de Saúde (BR). Resolução n°510, de 7 de abril de 2016. Dispõe sobre as normas aplicáveis a pesquisas em Ciências Humanas e Sociais cujos procedimentos metodológicos envolvam a utilização de dados diretamente obtidos com os participantes ou de informações identificáveis ou que possam acarretar riscos maiores do que os existentes na vida cotidiana, na forma definida nesta Resolução [Internet]. Diário Oficial da União, Brasília, DF. 2016 maio 24 [acess 2024 nov 7]; Seção 1:44. Disponível em: http://bvsms.saude.gov.br/bvs/saudelegis/cns/2016/res0510_07_04_2016.html
Gamage AU, Gunasekera T, Silva A. PS-P06-1: reduced healthcare utilization among patients with chronic diseases during the pandemic. J Hypertension. 2023;41(Suppl1):e253 doi: https://www.doi.org/10.1097/01.hjh.0000915300.70353.95 DOI: https://doi.org/10.1097/01.hjh.0000915300.70353.95
Schäfer I, Haack A, Neumann M, et al. Nichtinanspruchnahme medizinischer Leistungen in der COVID-19-Pandemie bei Personen mit chronischen Erkrankungen [Non-utilisation of medical services during the COVID-19 pandemic among persons with chronic diseases]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2023;66(3):275-82. doi: https://www.doi.org/10.1007/s00103-023-03665-9 DOI: https://doi.org/10.1007/s00103-023-03665-9
Lima LM, Castillo AA-D, Massaro C, et al. Psychological and financial impact of the COVID-19 pandemic during the first stages of the pandemic: brazilian orthodontists´ perspective. Dental Press J Orthod. 2023;27(6):e2221219. doi: https://www.doi.org/10.1590/2177-6709.27.6.e2221219.oar DOI: https://doi.org/10.1590/2177-6709.27.6.e2221219.oar
Schoonbeek RC, Jel DVC, van Dijk BAC, et al. Fewer head and neck cancer diagnoses and faster treatment initiation during COVID-19 in 2020: a nationwide population-based analysis. Radiother Oncol. 2022;167:42-8. doi: https://www.doi.org/10.1016/j.radonc.2021.12.005 DOI: https://doi.org/10.1016/j.radonc.2021.12.005
Ito FA, Ito K, Vargas PA, et al. Salivary gland tumors in a Brazilian population: a retrospective study of 496 cases. Int J Oral Maxillofac Surg. 2005;34(5):533-6. doi: https://www.doi.org/10.1016/j.ijom.2005.02.005 DOI: https://doi.org/10.1016/j.ijom.2005.02.005
Cohen Goldemberg D, Alves LDB, Antunes HS, et al. Epidemiology of major salivary gland cancer in Brazil: Incidence, morbidity, and mortality. Oral Dis. 2023;29(2):707-13. doi: https://www.doi.org/10.1111/odi.13896 DOI: https://doi.org/10.1111/odi.13896
Fu JY, Wu CX, Shen SK, et al. Salivary gland carcinoma in Shanghai (2003-2012): an epidemiological study of incidence, site and pathology. BMC Cancer. 2019;19(1):350. doi: https://www.doi.org/10.1186/s12885-019-5564-x DOI: https://doi.org/10.1186/s12885-019-5564-x
Iwata AJ, Williams AM, Taylor AR, et al. Socioeconomic disparities and comorbidities, not race, affect salivary gland malignancy survival outcomes. Laryngoscope. 2017;127(11):2545-50. doi: https://www.doi.org/10.1002/lary.26633 DOI: https://doi.org/10.1002/lary.26633
Soares EC, Bastos Neto BC, Santos LPS. Estudo epidemiológico do câncer de boca no Brasil/Epidemiological study of oral cancer in Brazil. Arq Med Hosp Fac Cienc Med Santa Casa São Paulo. 2019;64(3):192. doi: https://www.doi.org/10.26432/1809-3019.2019.64.3.192 DOI: https://doi.org/10.26432/1809-3019.2019.64.3.192
Cipriano TSP, Machado ATGM, Abreu MHNG, et al. Evaluation of the availability of secondary dental care within the Brazilian public health system: a cross-sectional study. CLCS. 2023;16(8):13331-46. doi: https://www.doi.org/10.55905/revconv.16n.8-262 DOI: https://doi.org/10.55905/revconv.16n.8-262
Rodriguez CP, Parvathaneni U, Méndez E, et al. Salivary gland malignancies. Hematol Oncol Clin North Am. 2015;29(6):1145-57. doi: https://www.doi.org/10.1016/j.hoc.2015.08.002 DOI: https://doi.org/10.1016/j.hoc.2015.08.002
Cheung MC, Franzmann E, Sola JE, et al. A comprehensive analysis of parotid and salivary gland cancer: worse outcomes for male gender. J Surg Res. 2011;171(1):151-8. doi: https://www.doi.org/10.1016/j.jss.2009.11.721 DOI: https://doi.org/10.1016/j.jss.2009.11.721
Mallik S, Agarwal J, Gupta T, et al. Prognostic factors and outcome analysis of submandibular gland cancer: a clinical audit. J Oral Maxillofac Surg. 2010;68(9):2104-10. doi: https://www.doi.org/10.1016/j.joms.2009.09.030 DOI: https://doi.org/10.1016/j.joms.2009.09.030
Migowski A, Corrêa FM. Recommendations for cancer early detection during COVID-19 pandemic in 2021. Rev APS [Internet]. 2020[access 2024 dec 12];23(1):241-46. Available from: https://ninho.inca.gov.br/jspui/handle/123456789/9638
Patrascu E, Melinte V, Paraschiv-Ferariu C, et al. Treatment difficulties in salivary gland cancer. Roman J Rhinol. 2019;9(34):83-9. doi: https://www.doi.org/10.2478/rjr-2019-0010 DOI: https://doi.org/10.2478/rjr-2019-0010
Palamim CVC, Marson FAL. COVID-19 - The availability of ICU beds in Brazil during the onset of pandemic. Ann Glob Health. 2020;86(1):100. doi: https://www.doi.org/10.5334/aogh.3025 DOI: https://doi.org/10.5334/aogh.3025
Lo Giudice G, Colella G, Boschetti CE, et al. Increased delay in diagnosis, but not treatment, among patients with oral cancer during the COVID-19 pandemic. JAMA Otolaryngol Head Neck Surg. 2023;149(1):91-2. doi: https://www.doi.org/10.1001/jamaoto.2022.3652 DOI: https://doi.org/10.1001/jamaoto.2022.3652
Graboyes EM, Kompelli AR, Neskey DM, et al. Association of treatment delays with survival for patients with head and neck cancer: a systematic review. JAMA Otolaryngol Head Neck Surg. 2019;145(2):166-77. doi: https://www.doi.org/10.1001/jamaoto.2018.2716 DOI: https://doi.org/10.1001/jamaoto.2018.2716
Su WW, Lee YH, Yen AM, et al. Impact of treatment delay on survival of oral/oropharyngeal cancers: results of a nationwide screening program. Head Neck. 2021;43(2):473-84. doi: https://www.doi.org/10.1002/hed.26504 DOI: https://doi.org/10.1002/hed.26504
van Harten MC, Hoebers FJ, Kross KW, et al. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015;51(3):272-8. doi: https://www.doi.org/10.1016/j.oraloncology.2014.12.003 DOI: https://doi.org/10.1016/j.oraloncology.2014.12.003
Gillespie MB, Albergotti WG, Eisele DW. Recurrent salivary gland cancer. Curr Treat Options Oncol. 2012;13(1):58-70. doi: https://www.doi.org/10.1007/s11864-011-0174-0 DOI: https://doi.org/10.1007/s11864-011-0174-0
Linxweiler M, Kuo F, Katabi N, et al. The Immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype. Clin Cancer Res. 2020;26(12):2859-70. doi: https://www.doi.org/10.1158/1078-0432.CCR-19-3758 DOI: https://doi.org/10.1158/1078-0432.CCR-19-3758
Cunha AR, Velasco SRM, Hugo FN, et al. Hospitalizations for oral and oropharyngeal cancer in Brazil by the SUS: impacts of the covid-19 pandemic. Rev Saúde Pública. 2023;57:3s. doi: https://www.doi.org/10.11606/s1518-8787.2023057004708 DOI: https://doi.org/10.11606/s1518-8787.2023057004708
Silva MJS, O’Dwyer G, Osorio-de-Castro CGS. Cancer care in Brazil: structure and geographical distribution. BMC Cancer. 2019;19(1):987. doi: https://www.doi.org/10.1186/s12885-019-6190-3 DOI: https://doi.org/10.1186/s12885-019-6190-3
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
